Effect of IL17 Inhibitor in Comparison With Anti-TNF in Patients With Ankylosing Spondylitis
ClinicalTrials.gov ID NCT06642207 Sponsor Sohag University Information provided by Manar Gamal Abdelfattah, Sohag University (Responsible Party) Last Update Posted 2024-10-30 Brief Summary Ankylosing spondylitis (AS) is a chronic, inflammatory autoimmune disease characterized by axial bone inflammation. The main clinical manifestations include back pain and progressive spinal rigidity, as well as [READ MORE]